Remicade® IV Infusion Vial for Clinics

What Remicade Is and How It Works

Remicade® (Non-English) is a vial presentation of infliximab supplied as a sterile powder for intravenous infusion. Clinics integrate this product into supervised infusion services across rheumatology, gastroenterology, and dermatology. Teams keep it on hand for standardized workflows and dependable access under US distribution.

This monoclonal antibody targets tumor necrosis factor-alpha (TNF-α), a central cytokine involved in inflammatory pathways. It is prepared and administered by trained professionals in controlled settings. Med Wholesale Supplies serves licensed clinics and healthcare professionals with authentic, brand-name medical products sourced through vetted distributors.

The product supports infusion-center protocols that emphasize aseptic preparation, patient monitoring, and post-infusion observation. For broader therapeutic context and operational considerations, see our in-depth Remicade Overview and browse related Pharmaceuticals.

Professional Applications

Infusion suites use this preparation within prescriber-directed pathways that may include pre-infusion screening and observation. Programs often schedule chair time alongside other biologic infusions to optimize staffing and throughput. Rheumatology and gastroenterology clinics may coordinate with pharmacy services for preparation and verification steps. When incorporating Remicade® (Non-English), teams typically align workflows to existing biologic handling SOPs and infusion safety checklists. For GI-focused alternatives within the same operational model, review Entyvio.

Key Features

• Remicade Non-English packaging: labeled in a non-English language for clinics comfortable with that format
• Sterile biologic quality: supplied as a preservative-free, single-use presentation
• TNF-alpha targeting: chimeric monoclonal antibody mechanism consistent with class standards
• Intravenous use: reconstituted and administered by qualified staff in infusion settings
• Lot and expiry clarity: exterior carton and vial labels support inventory tracking
• Workflow fit: compatible with established infusion-center preparation and monitoring protocols
• Aseptic preparation: supports controlled reconstitution and IV administration procedures
• GMP sourcing: produced to recognized pharmaceutical manufacturing standards

Benefits in Practice

Infusion teams value this product for predictable handling, consistent labeling, and a supply format that integrates smoothly with pharmacy verification and chair scheduling. It supports centralized preparation and controlled administration, helping maintain throughput while preserving safety routines. The vial design aligns with single-patient use policies that many centers enforce.

Operationally, it can streamline standard tasks: pulling stock by lot, preparing under aseptic technique, documenting batch details, and coordinating observation windows. Using Remicade® (Non-English) within established SOPs may reduce variability across staff shifts and sites. Clinics can also align staff education with class-wide principles for anti-TNF biologics, including readiness to manage infusion-related reactions.

Infusion services commonly maintain response protocols for immediate or delayed infusion events. Typical adverse effects may include headache, nausea, diarrhea, mild respiratory infections, and infusion reactions. As with other agents in this class, there may be an increased risk of infections and potential development of antibodies to the biologic. Establishing screening, vaccination review, and escalation pathways supports safe administration.

For centers evaluating similar infusion options used in immune-mediated care, see MabThera and review broader biologic considerations in our Actemra Guide.

Composition & Ingredients

Infliximab is the active monoclonal antibody that binds TNF-α. The vial is supplied as a sterile powder for reconstitution and intravenous infusion under professional supervision. For clinics documenting product specifics in their formulary or EMR, this entry corresponds to infliximab supplied as Infliximab powder for infusion 100 mg. Inactive components are present; consult the carton and accompanying documentation for the full excipient list provided with the batch.

• Active ingredient: infliximab (anti–TNF-alpha monoclonal antibody)
• Excipients: see package labeling and insert for full details

Packaging & Supply

This presentation is a single-use vial packaged in a carton containing one vial. Lot number and expiry are displayed to support receiving checks and inventory documentation. Clinics should maintain the carton and label information through preparation and administration to ensure traceability across records. For clarity on presentation lineage and product family, see the Remicade Brand page.

For inventory notation, this item is associated with SKU 87919 in our catalogue. The presentation corresponds to Infliximab 100 mg vial, supplied with non-English labeling as listed above. Always follow the label and internal SOPs for storage, handling, preparation, and disposal. If your formulary references alternative biologics within the same operational category, explore Pharmaceuticals for additional options.

Ordering & Logistics

Account verification is required for ordering. After approval, sign in to view volume and contract pricing, confirm clinic eligibility, and submit purchase requests through your assigned account. Orders can be aligned with your infusion schedule planning, with lead times coordinated through your purchasing workflow. If your facility uses centralized receiving, include departmental routing so pharmacy and infusion teams can stage reconstitution and administration efficiently.

Your order history, lot preferences, and documentation can be managed within your account. Coordinate any delivery windows with your operations lead to support staff availability for intake and storage. For questions about documentation provided with the carton, contact your representative prior to scheduling patients.

Comparable Products

Clinics evaluating category alternatives often review agents with similar infusion-center workflows. Consider Entyvio for GI-focused infusion programs or MabThera where hematology–rheumatology protocols apply. Selection should follow prescriber direction, formulary criteria, and site-specific SOPs.

Pricing & Access

Sign in to access tiered pricing based on volume commitments and contract terms. Quotes can be aligned to multi-site procurement and budget cycles. If your facility requires product profiles for P&T review, our team can provide standard product information on request. Reference Remicade® (Non-English) when adding this item to your formulary notes to match labeling and documentation.

Availability & Substitutions

Supply can vary by batch and distributor intake. If you require a substitution, confirm clinical interchangeability and protocol fit with the prescriber and your pharmacy lead before updating schedules. We can suggest class alternatives carried in our catalogue; final selection should align with your facility’s clinical guidance and patient-specific considerations. No restock timelines are guaranteed.

Authoritative Sources

• MedlinePlus: Infliximab
• FDA: TNF Blockers
• NCBI: Infliximab Overview

Ready to proceed? Sign in to request this item with temperature-controlled handling when required and tracked US delivery.